PT3830120T - Nova proteína de fusão específica para cd137 e pd-l1 - Google Patents

Nova proteína de fusão específica para cd137 e pd-l1

Info

Publication number
PT3830120T
PT3830120T PT197460892T PT19746089T PT3830120T PT 3830120 T PT3830120 T PT 3830120T PT 197460892 T PT197460892 T PT 197460892T PT 19746089 T PT19746089 T PT 19746089T PT 3830120 T PT3830120 T PT 3830120T
Authority
PT
Portugal
Prior art keywords
fusion protein
protein specific
novel fusion
novel
specific
Prior art date
Application number
PT197460892T
Other languages
English (en)
Original Assignee
Servier Lab
Pieris Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Pieris Pharmaceuticals Gmbh filed Critical Servier Lab
Publication of PT3830120T publication Critical patent/PT3830120T/pt

Links

PT197460892T 2018-11-06 2019-07-31 Nova proteína de fusão específica para cd137 e pd-l1 PT3830120T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18204548 2018-11-06

Publications (1)

Publication Number Publication Date
PT3830120T true PT3830120T (pt) 2023-06-29

Family

ID=64456743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197460892T PT3830120T (pt) 2018-11-06 2019-07-31 Nova proteína de fusão específica para cd137 e pd-l1

Country Status (2)

Country Link
EA (1) EA202092606A1 (pt)
PT (1) PT3830120T (pt)

Also Published As

Publication number Publication date
EA202092606A1 (ru) 2021-05-14

Similar Documents

Publication Publication Date Title
ZA202100125B (en) Novel fusion protein specific for cd137 and pd-l1
GB2564823B (en) Compositions and methods for TCR reprogramming using fusion proteins
EP3880814A4 (en) FUSION PROTEIN
EP3298033A4 (en) Compositions and methods for tcr reprogramming using fusion proteins
SG11202012004SA (en) Rna-targeting fusion protein compositions and methods for use
EP3348571A4 (en) SINGLE DOMAIN ANTIBODY FOR LIGAND OF PROGRAMMED CELLULAR DEATH RECEPTOR (PD-L1) AND PROTEIN DERIVED THEREFROM
EP3287470A4 (en) Novel recombinant bi-functional fusion protein and preparation and application therefor
IL284687A (en) Novel fusion proteins specific for CD137 and GPC3
EP3280727A4 (en) TYPE I AND SINGLE-ARM TYPE II RECEPTOR FUSION PROTEINS AND USES THEREOF
SG11202008721SA (en) Compositions and methods for tcr reprogramming using fusion proteins
EP3147298A4 (en) Pd-l1 fusion protein and use thereof
IL287318A (en) Materials and methods for the production of proteins
SG11202101811VA (en) Compositions and methods for tcr reprogramming using fusion proteins
ZA202003845B (en) Fusion proteins
SG11202101904UA (en) Spd-1 variant - fc fusion proteins
ZA202102533B (en) Fusion protein
IL291284A (en) Systems and methods for expression of proteins
IL281397B (en) Human pd–l1 antibodies
IL291236A (en) Compositions and methods for reprogramming tcr using fusion proteins
SG11202000775SA (en) Fusion tags for recombinant protein expression
EP3317297A4 (en) BTLA AGONIST FUSION PROTEIN AND USES THEREOF
IL290715A (en) nkg2d fusion proteins and their use
EP4034565A4 (en) PD-L1 TARGETED CHIMERIC PROTEINS AND THEIR USES
EP3740501A4 (en) FUSION PROTEIN EXTENSIONS
EP3647426A4 (en) FUSION PROTEIN